Related Experiment Video

Updated: Aug 23, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Mutually exclusive mutations of the Pten and ras pathways in skin tumor progression

Jian-Hua Mao1, Minh D To, Jesus Perez-Losada

  • 1University of California at San Francisco Comprehensive Cancer Center, San Francisco, California 94143, USA.

Genes & Development
|August 4, 2004
PubMed

Insights

Loss of Pten in mice accelerates skin cancer formation. Tumors with complete Pten loss do not require H-ras mutations, unlike those retaining Pten, impacting cancer therapy strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pten heterozygous (Pten+/-) mice exhibit accelerated skin tumor development after chemical carcinogen exposure.
  • H-ras mutations are common in chemically induced skin tumors, but their role in Pten-deficient cancers is unclear.

Purpose of the Study:

  • To investigate the interplay between Pten loss and H-ras mutations in skin carcinoma development.
  • To determine the role of MAPK signaling in Pten-deficient skin carcinogenesis.

Main Methods:

  • Utilized Pten+/- mice and chemical carcinogens (DMBA and TPA) to induce skin tumors.
  • Analyzed tumor genotypes for H-ras mutations and Pten allele status.
  • Assessed MAPK pathway activation in different tumor types.

Main Results:

  • Pten+/- mice developed more papillomas and faster carcinomas than controls.
  • 70% of Pten+/- carcinomas lacked H-ras mutations but showed loss of wild-type Pten.
  • H-ras mutations and complete Pten loss were mutually exclusive; MAPK was activated in H-ras mutated tumors but downregulated in Pten-null tumors.

Conclusions:

  • Complete Pten loss can drive skin carcinoma formation independently of H-ras mutations.
  • The MAPK pathway is not essential for skin carcinoma development when Pten is lost.
  • Findings suggest distinct molecular pathways in skin carcinogenesis, with implications for targeted cancer therapies.

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...